Table 4.
Changes in observed indices pre-treatment and post-treatment of a transabdominal surgery group and a laparoscopic surgery group .
| Pre-treatment |
Post-treatment |
P | P * | |||
|---|---|---|---|---|---|---|
| Transabdominal surgery group (n = 31) | Laparoscopic surgery group (n = 33) | Transabdominal surgery group (n = 31) | Laparoscopic surgery group (n = 33) | |||
| Hemoglobin value (g/L) | 99.71 ± 18.40 (72–138) | 109.52 ± 19.41 (79–144) | 117.13 ± 10.38 (102–142) | 118.97 ± 9.01 (102–135) | .000 | .000 |
| CA125 (U/ml) | 111.55 ± 133.96 (11.71–749.90) | 74.87 ± 63.10 (17.38–249.80) | 12.54 ± 8.53 (4.58–45.36) | 15.71 ± 9.18 (7.36–45.35) | .000 | .000 |
| Dysmenorrhea score (points) | 8.39 ± 0.67 (7–9) | 7.68 ± 1.38 (7–9) | 1.23 ± 0.67 (0–2) | 1.48 ± 0.62 (1–3) | .000 | .000 |
| Menstrual volume score (points) | 130.29 ± 12.94 (105–162) | 129.09 ± 24.06 (106–166) | 21.87 ± 7.50 (3–31) | 22.76 ± 10.50 (3–48) | .000 | .000 |
| Uterine volume (cm3) | 198.80 ± 80.64 (87.55–340.70) | 147.20 ± 63.80 (76.58–335.95) | 38.83 ± 15.14 (16.47–73.36) | 49.51 ± 17.08 (14.71–80.70) | .000 | .000 |
Hemoglobin value is for 3 months post-treatment; CA125 is for 1-month post-treatment; dysmenorrhea score and menstrual volume score are for the first menstrual period after GnRH-a injection; uterine volume is for 3 months post-treatment. P: Statistical analysis of a transabdominal surgery group pre-treatment and post-treatment.
*
P: Statistical analysis of a laparoscopic surgery group pre-treatment and post-treatment.